Literature DB >> 18362059

Impact of cancer-related symptom synergisms on health-related quality of life and performance status.

Karine A S L Ferreira1, Miako Kimura, Manoel J Teixeira, Tito R Mendoza, Jose Cláudio M da Nóbrega, Silvia R Graziani, Teresa Yae Takagaki.   

Abstract

To identify the impact of multiple symptoms and their co-occurrence on health-related quality of life (HRQOL) dimensions and performance status (PS), 115 outpatients with cancer, who were not receiving active cancer treatment and were recruited from a university hospital in Sao Paulo, Brazil completed the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30, the Beck Depression Inventory, and the Brief Pain Inventory. Karnofsky Performance Status scores also were completed. Application of TwoStep Cluster analysis resulted in two distinct patient subgroups based on 113 patient experiences with pain, depression, fatigue, insomnia, constipation, lack of appetite, dyspnea, nausea, vomiting, and diarrhea. One group had multiple and severe symptom subgroup and another had less symptoms and with lower severity. Multiple and severe symptoms had worse PS, role functioning, and physical, emotional, cognitive, social, and overall HRQOL. Multiple and severe symptom subgroup was also six times as likely as lower severity to have poor role functioning; five times more likely to have poor emotional; four times more likely to have poor PS, physical, and overall HRQOL; and three times as likely to have poor cognitive and social HRQOL, independent of gender, age, level of education, and economic condition. Classification and Regression Tree analyses were undertaken to identify which co-occurring symptoms would best determine reduction in HRQOL and PS. Pain and fatigue were identified as indicators of reduction on physical HRQOL and PS. Fatigue and insomnia were associated with reduction in cognitive; depression and pain in social; and fatigue and constipation in role functioning. Only depression was associated with reduction in overall HRQOL. These data demonstrate that there is a synergic effect among distinct cancer symptoms that result in reduction in HRQOL dimensions and PS.

Entities:  

Mesh:

Year:  2008        PMID: 18362059     DOI: 10.1016/j.jpainsymman.2007.07.010

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  29 in total

1.  Longitudinal Examination of Symptom Profiles Among Breast Cancer Survivors.

Authors:  Nancy E Avis; Beverly Levine; Sarah A Marshall; Edward H Ip
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

2.  Factors related to clinically relevant fatigue in disease-free stomach cancer survivors and expectation-outcome consistency.

Authors:  In Cheol Hwang; Young Ho Yun; Young-Woo Kim; Keun Won Ryu; Young Ae Kim; Sung Kim; Jae-Moon Bae; Jae-Hyung Noh; Tae-Sung Sohn
Journal:  Support Care Cancer       Date:  2014-01-09       Impact factor: 3.603

3.  Efficacy of pain education in cancer patients: a meta-analysis of randomized controlled trials.

Authors:  Hyun Jung Jho; Seung-Kwon Myung; Yoon-Jung Chang; Dae-Hyun Kim; Doo Heun Ko
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

Review 4.  A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment.

Authors:  Carolyn Miller Reilly; Deborah Watkins Bruner; Sandra A Mitchell; Lori M Minasian; Ethan Basch; Amylou C Dueck; David Cella; Bryce B Reeve
Journal:  Support Care Cancer       Date:  2013-01-12       Impact factor: 3.603

5.  Identification of symptom clusters among patients with heart failure: an international observational study.

Authors:  Debra K Moser; Kyoung Suk Lee; Jia-Rong Wu; Gia Mudd-Martin; Tiny Jaarsma; Tsuey-Yuan Huang; Xui-Zhen Fan; Anna Strömberg; Terry A Lennie; Barbara Riegel
Journal:  Int J Nurs Stud       Date:  2014-02-28       Impact factor: 5.837

6.  Impact of symptom burden in post-surgical non-small cell lung cancer survivors.

Authors:  Amy E Lowery; Paul Krebs; Elliot J Coups; Marc B Feinstein; Jack E Burkhalter; Bernard J Park; Jamie S Ostroff
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

7.  Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease.

Authors:  Soo Kyung Park; Catherine A Meldrum; Janet L Larson
Journal:  Heart Lung       Date:  2013-09-20       Impact factor: 2.210

8.  Latent Class Analysis Reveals Distinct Subgroups of Patients Based on Symptom Occurrence and Demographic and Clinical Characteristics.

Authors:  Christine Miaskowski; Laura Dunn; Christine Ritchie; Steven M Paul; Bruce Cooper; Bradley E Aouizerat; Kimberly Alexander; Helen Skerman; Patsy Yates
Journal:  J Pain Symptom Manage       Date:  2015-01-31       Impact factor: 3.612

9.  Congruence Between Latent Class and K-Modes Analyses in the Identification of Oncology Patients With Distinct Symptom Experiences.

Authors:  Nikoloas Papachristou; Payam Barnaghi; Bruce A Cooper; Xiao Hu; Roma Maguire; Kathi Apostolidis; Jo Armes; Yvette P Conley; Marilyn Hammer; Stylianos Katsaragakis; Kord M Kober; Jon D Levine; Lisa McCann; Elisabeth Patiraki; Steven M Paul; Emma Ream; Fay Wright; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-08-30       Impact factor: 3.612

10.  The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.

Authors:  C Miaskowski; B A Cooper; B Aouizerat; M Melisko; L-M Chen; L Dunn; X Hu; K M Kober; J Mastick; J D Levine; M Hammer; F Wright; J Harris; J Armes; E Furlong; P Fox; E Ream; R Maguire; N Kearney
Journal:  Eur J Cancer Care (Engl)       Date:  2016-01-18       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.